Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    20492850 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
An Open-Label Trial of Tocilizumab in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Tocilizumab
2 Recruiting Siltuximab in Schizophrenia
Conditions: Schizophrenia;   Psychotic Disorders
Interventions: Drug: Siltuximab;   Drug: normal saline
3 Not yet recruiting Aspirin in Young Psychotic Patients
Conditions: Psychosis;   Acute Psychosis;   Schizophrenia
Interventions: Drug: Aspirin;   Drug: Placebo;   Drug: Pantoprazole

Study has passed its completion date and status has not been verified in more than two years.